NOV 01, 2020 7:49 AM PST

SARS-CoV-2 Disrupts the Blood Brain Barrier

WRITTEN BY: Carmen Leitch

SARS-CoV-2, which causes COVID-19 has to get into cells to cause infection. It does so with a spike protein on its surface; this spike protein can attach to receptors on human host cells. For example, the spike protein can bind to ACE2 receptors on the surfaces of cells that line the nose and lungs. While the virus was first known as one that affected the respiratory system, clinicians and researchers now know that it can affect other tissues including blood vessels, and neurological symptoms like dizziness, brain fog, and headache have been observed in many patients.

This SEM image shows SARS-CoV-2 (round blue objects) emerging from the surface of cells cultured in the lab. The virus shown was isolated from a patient in the U.S. / Image credit: cropped from NIAID/Rocky Mountain Laboratories (RML) in Hamilton, Montana

Researchers are trying to learn more about how the virus may impact the brain. Scientists have now reported in the Neurobiology of Disease that the spike protein of the SARS-CoV-2 virus can disrupt the blood-brain barrier.

"Previous studies have shown that SARS-CoV-2 infects host cells by using its spike proteins to bind to the angiotensin-converting enzyme 2 (ACE2) on the host cell surface," explained principle study author Servio H. Ramirez, Ph.D., a Professor of Pathology and Laboratory Medicine at the Lewis Katz School of Medicine at Temple University. "Since ACE2 is a major binding target for SARS-CoV-2 in the lungs and vasculature of other organs in the body, tissues that are behind the vasculature, that receive blood from affected vessels, are at risk of damage from the virus."

What has been unclear is whether ACE2 is also normally found in the brain's blood vessels or if COVID-19 causes conditions that change the expression pattern of ACE2.

In this work, the researchers assessed the postmortem brain samples of (previously) healthy individuals as well as people that were hypertensive or had dementia. The scientists found that ACE2 can be found throughout the blood vessels in the frontal cortex of the human brain, but the level of ACE2 receptors is significantly increased in people that had hypertension or dementia.

Using a cell culture model, the scientists also determined that when cells were exposed to the spike protein or a portion of it called subunit 1, there were declines in the integrity of the endothelial barrier. Subunit 2 appeared to have a direct impact on the function of the blood-brain barrier.

"This is of importance because unlike subunit 1, subunit 2 of the spike protein doesn't bind to ACE2, meaning that a breach to the blood-brain barrier could occur in a manner that is independent of ACE2," noted the first study author, postdoctoral fellow Tetyana P. Buzhdygan, Ph.D.

Additional research with microfluidic devices that were meant to mimic capillaries suggested that the spike protein can increase the permeability of their walls.

"Our findings support the implication that SARS-CoV-2, or its shed spike proteins circulating in the bloodstream, could cause destabilization of the blood-brain barrier in key brain regions," Dr. Ramirez said. "Altered function of this barrier, which normally keeps harmful agents out of the brain, greatly increases the possibility of neuroinvasion by this pathogen, offering an explanation for the neurological manifestations experienced by COVID-19 patients."

We still have more to learn about the lasting neurological impacts of the virus, as well as whether it's able to directly infect neurons behind the blood-brain barrier. It does appear that a different human coronavirus, SARS-CoV, was able to invade the CNS directly.

"The viral genome has not been found yet in the specific cell types of the brain," said Dr. Ramirez. "The next steps in our work are to look for genomic viral copies in different parts of the brain using autopsy material from COVID-19 cases and to investigate the pathogen's ability to neuroinvade using different cell culture and tissue-engineered constructs."

Sources: AAAS/Eurekalert! via Temple University Health System, Neurobiology of Disease

About the Author
  • Experienced research scientist and technical expert with authorships on over 30 peer-reviewed publications, traveler to over 70 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
NOV 19, 2020
Immunology
Parasitic Worms Help Unravel the Immune Mechanisms Underlying Chronic Disease
NOV 19, 2020
Parasitic Worms Help Unravel the Immune Mechanisms Underlying Chronic Disease
Parasitic worms known as helminths have a complicated relationship with the immune systems of the hosts they invade. Ter ...
NOV 25, 2020
Immunology
The History of Vaccines
NOV 25, 2020
The History of Vaccines
Everyone worldwide is sitting with anticipation, waiting for the right vaccine candidate for the coronavirus outbreak, h ...
DEC 04, 2020
Microbiology
Why Cases of COVID-19 Tend to be Milder in Children
DEC 04, 2020
Why Cases of COVID-19 Tend to be Milder in Children
Although children can get infected with SARS-CoV-2, the virus that causes COVID-19, and spread it to others, they are mo ...
DEC 21, 2020
Genetics & Genomics
Tracing the Evolution of a Deadly Microbe
DEC 21, 2020
Tracing the Evolution of a Deadly Microbe
Salmonella are human & animal bacterial pathogens that are found everywhere. When the bacterium infects a person, it cau ...
JAN 14, 2021
Microbiology
Decontaminating the Cancer Microbiome
JAN 14, 2021
Decontaminating the Cancer Microbiome
Valid scientific conclusions require a solid foundation of good data that comes from reliable techniques. Studies that i ...
FEB 24, 2021
Microbiology
The Human Gut Microbiome is Teeming With Viruses
FEB 24, 2021
The Human Gut Microbiome is Teeming With Viruses
Using metagenomics tools, which sequence all of the viral material in a sample, researchers have investigated the viruse ...
Loading Comments...